Biochemical Impact of Dexmedetomidine on Inflammatory and Stress Markers in Gastric Cancer Surgery: A Meta-Analysis

Serum Markers in Dexmedetomidine Anesthesia

  • Xuhui Zhang Department of Anesthesiology, The 305 Hospital of PLA
  • Wenjun Hu Department of Anesthesiology, The 305 Hospital of PLA
  • Jinghua Wang Department of Anesthesiology, The 305 Hospital of PLA
  • Rui Qin Department of Gastroenterology, The 305 Hospital of PLA
  • Xinlei Wang Department of Anesthesiology, The 305 Hospital of PLA
  • Zhenhua Zhang Department of Gastroenterology, The 305 hospital of PLA
Keywords: Dexmedetomidine, Inflammatory markers, Stress hormones, Gastric cancer, Meta-analysis, Biochemical modulation

Abstract


Background: Dexmedetomidine, an α2-adrenergic agonist, has been reported to modulate inflammatory responses and neuroendocrine stress in surgical settings. This meta-analysis evaluated its effects on serum biochemical markers of inflammation and stress in patients undergoing gastric cancer surgery.

Methods: Literature was retrieved from PubMed, CNKI, Wanfang, and VIP databases. Studies comparing dexmedetomidine anesthesia with conventional regimens in gastric cancer surgery were included. RevMan 5.2 was used for meta-analysis. Outcome indicators included interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), cortisol, epinephrine, adrenocorticotropic hormone (ACTH), heart rate (HR), mean arterial pressure (MAP), and adverse events.

Results: Fifteen studies were analyzed. Compared with controls, dexmedetomidine significantly reduced serum levels of IL-6, TNF-α, cortisol, epinephrine, and ACTH (all P < 0.00001). It also decreased HR, MAP, visual analog scale (VAS) scores, and incidence of adverse reactions.

Conclusion: Dexmedetomidine anesthesia effectively reduces biochemical markers of inflammation and stress in gastric cancer surgery, suggesting its beneficial role in modulating perioperative biochemical responses.

References

1. Lopez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hemat 2023; 181: 103841.
2. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne 2022; 20(2): 167-92.
3. Kwon JH, Kim J, Yeo H, Kim K, Rhu J, Choi GS, et al. Recurrence-free survival after hepatectomy using propofol-based total intravenous anaesthesia and sevoflurane-based inhalational anaesthesia: a randomised controlled study. Anaesthesia 2025; 80(4): 366-77.
4. Fang T, Lin L, Ye ZJ, Fang L, Shi S, Yu KD, et al. Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through alpha (2)-AR/HIF-1alpha/VEGFA Pathway. Biomed Environ Sci 2022; 35(10): 931-42.
5. Ma XF, Lv SJ, Wei SQ, Mao BR, Zhao XX, Jiang XQ, et al. Influences of dexmedetomidine on stress responses and postoperative cognitive and coagulation functions in patients undergoing radical gastrectomy under general anesthesia. World J Gastro Surg 2023; 15(6): 1169-77.
6. Liao YQ, Min J, Wu ZX, Hu Z. Comparison of the effects of remimazolam and dexmedetomidine on early postoperative cognitive function in elderly patients with gastric cancer. Front Aging Neurosci 2023; 15: 1123089.
7. Persson N, Uusalo P, Nedergaard M, Lohela TJ, Lilius TO. Could dexmedetomidine be repurposed as a glymphatic enhancer? Trends Pharmacol Sci 2022; 43(12): 1030-40.
8. Zeng H, Yin F, Fan L, Li C, Lin H, Liu F, et al. Combination of dexamethasone and dexmedetomidine as adjuvants of transversus abdominis plane block for postoperative analgesia in gastric cancer patients: A double-blinded randomized controlled trial. J Clin Anesth 2024; 97: 111543.
9. Liao YQ, Min J, Wu ZX, Hu Z. Comparison of the effects of remimazolam and dexmedetomidine on early postoperative cognitive function in elderly patients with gastric cancer. Front Aging Neurosci 2023; 15: 1123089.
10. Zhang Y, Zhou Y, Hu T, Tong X, He Y, Li X, et al. Dexmedetomidine reduces postoperative pain and speeds recovery after bariatric surgery: a meta-analysis of randomized controlled trials. Surg Obes Relat Dis 2022; 18(6): 846-53.
11. Li Y, Wang Y, Chang H, Cheng B, Miao J, Li S, et al. Inhibitory Effects of Dexmedetomidine and Propofol on Gastrointestinal Tract Motility Involving Impaired Enteric Glia Ca(2+) Response in Mice. Neurochem Res 2021; 46(6): 1410-22.
12. Chang PC, Huang IY, Liu SD, Huang CK, Lin TE, Jhou HJ, et al. Perioperative Dexmedetomidine Infusion Improves Perioperative Care of Bariatric-Metabolic Surgery: A Single Center Experience with Meta-Analysis. Obes Surg 2024; 34(2): 416-28.
13. Mei M, Yao M, Li J, Qiu C, Wang Y, Li Y, et al. Influences of different sedatives on gastric antrum contraction in patients with acute brain injury. Front Neurol 2024; 15: 1492604.
14. Liu Y, Shen Y, Zhong H. Dexmedetomidine-Propofol Versus Propofol Alone for Sedation in Upper Gastrointestinal Endoscopic Ultrasound: A Randomized Comparative Study. Clin Ther 2025:
15. Kuo WT, Hsiao CY, Chou SC, Chiang CS, Chen TH, Lin CH, et al. Outcomes of postoperative preemptive sedation in the intensive care unit for geriatric patients with gastric cancer undergoing gastrectomy. J Chin Med Assoc 2025:
16. Kitano T, Okajima M, Sato K, Noda T, Taniguchi T. Suicidal attempt with caffeine overdose treated with dexmedetomidine: a case report. J Med Case Rep 2021; 15(1): 11.
17. Khatri S, Hannurkar P. Understanding and Treating Laryngeal Mask Airway-Induced Intraoperative Hiccups. Cureus J Med Science 2024; 16(9): e69782.
18. Wang M, Wang J, Li X, Xu X, Zhao Q, Li Y. A predictive model for postoperative cognitive dysfunction in elderly patients with gastric cancer: a retrospective study. Am J Transl Res 2022; 14(1): 679-86.
19. Ariga BK, Kanashiro GP, Vieira G, Peruchi LG, Nicacio GM, Cassu RN. Effects of pharmacopuncture with metamizole on postoperative pain and analgesic requirements in dogs undergoing ovariohysterectomy. Vet Anaesth Analg 2025; 52(3): 338-45.
20. Goel N, Jha R, Bhardwaj M, Chawla R. Comparison of Propofol-Dexmedetomidine-Based Intravenous and Sevoflurane-Based Inhalational Anesthesia in Patients Undergoing Modified Radical Mastectomy. Anesth Essays Res 2020; 14(3): 420-4.
21. Lim JY, Ker CJ, Lai NM, Romantsik O, Fiander M, Tan K. Dexmedetomidine for analgesia and sedation in newborn infants receiving mechanical ventilation. Cochrane Db Syst Rev 2024; 5(5): CD012361.
22. Zhang S, Fang W, Zhou S, Zhu D, Chen R, Gao X, et al. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nat Commun 2023; 14(1): 5123.
23. Zhang W, Zhang L, Cai XJ, Li D, Cao FJ, Zuo ZG, et al. Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1. Kaohsiung J Med Sci 2022; 38(6): 585-93.
24. Liu M, Wang B, Prudence B, Chen X. Effect of different doses of epidural dexmedetomidine on reducing visceral traction reaction for cesarean section: a double-blind randomized controlled trial. J Anesth 2023; 37(3): 371-8.
Published
2025/08/08
Section
Original paper